Company intelligence / Profile preview

Automic

Ownership: Private
Development stage: Other

Overview

AutOmics is a medical technology company specializing in the automation and digitization of tissue pathology workflows. The company provides an integrated platform that replaces fragmented manual steps with a continuous, high-throughput system and intelligent software, significantly improving throughput and reliability for hospital pathology departments and research institutions. By leveraging AI to aggregate and standardize outputs across the entire workflow, AutOmics creates structured multi-omics databases that support disease research and clinical decision-making. Their technology offers 100x resolution and 3D spatial insights, aiming to modernize pathology labs and unlock the value of previously siloed diagnostic data.

Therapeutic areas: OncologyOther
Modalities: AI-driven diagnosticsAutomated pathologyMulti-omics workflowsSpatial biology
Industry: Pathology

Beyond the preview

Go deeper on Automic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Automic.

Explore the full profile